Non–Small Cell Lung Cancer, Version 6.2015

Cited by (479)

Items 401–479 of 479

1. F-18 fluorodeoxyglucose uptake in lymph nodes and sonographic features on endobronchial ultrasonography predict lymph node metastasis in lung cancer patients
   Takashi Yamamichi, Masatoshi Kakihana, Yasuyuki Nitta, Wakako Hamanaka, Naohiro Kajiwara, Tatsuo Ohira, Norihiko Ikeda · 2020 · Journal of Thoracic Disease
2. GPC1-ALK: A novel ALK fusion in a patient with pulmonary sarcomatoid carcinoma
   Lei Xiong, Xiao Li, Dongsheng Chen, Si Li, Liguo Luo · 2020 · Lung Cancer
3. The Prognostic Impact of Lymph Node Dissection on Primary Tumor Resection for Stage IV Non–Small Cell Lung Cancer: A Population-Based Study
   Yudong Zhang, Yichi Zhang, Xinxin Cheng, Keyao Dai, Bo Xu, Shujun Liang, Minsheng Chen, Honglang Zhang, Zhenguang Chen · 2022 · Frontiers in Oncology
4. Construction of Lymph Node Metastasis-Related Prognostic Model and Analysis of Immune Infiltration Mode in Lung Adenocarcinoma
   Wujin Li, Debin Ou, Jiguang Zhang, Ming-fan Ye · 2022 · Computational and Mathematical Methods in Medicine
5. Avoiding Dosimetric Risk Factors for Complications in Neoadjuvant Chemoradiotherapy for Lung Cancer: Conventional Radiotherapy Versus Intensity-modulated Radiotherapy
   Shigeo Takahashi, Masahide Anada, TOSHIFUMI KINOSHITA, Takamasa Nishide, Toru Shibata · 2023 · Cancer Diagnosis & Prognosis
6. Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in Solutions
   Julia Rachel Trosman, Christine B. Weldon, Allison W. Kurian, Emily Hammad Mrig, Kathryn A. Phillips · 2025 · JCO Precision Oncology
7. Real-time margin assessment for video-assisted thoracic surgery: A pilot clinical trial
   Jagadeesan Jayender, Sarah Lobo, Alan Lucas, Julie Barlow, Ahmed Sadek, Zahra Sarawat Alam, Rajat Mukherjee, Eric J. Schmidlin, Michael T. Jaklitsch, Lynette Marie Sholl et al. · 2025 · JTCVS Techniques
8. Nanoengineered redox-responsive platforms for dual-targeted NSCLC therapy with tumor-on-a-chip epithelial-mesenchymal transition profiling
   Wenjing Ma, Haowen Tian, Jianbin Shi, Jia Deng, Naiyuan Hu, Wenqian Xu, Ayumi Kikkawa, Kaho Tanaka, Cong Luo, Ken‐ichiro Kamei et al. · 2025 · Chemical Engineering Journal
9. Automated contouring of gross tumor volume lymph nodes in lung cancer by deep learning
   Yuling Huang, Xingxing Yuan, Longfei Xu, Junming Jian, Changfei Gong, Yun Zhang, Wenheng Zheng · 2025 · BMC Cancer
10. Lung Cancer with Unexpected Localized Pleural Dissemination Detected during Surgery: Should We Stop Surgery or Should We Go On?
    Servet Bölükbas · 2015 · The Thoracic and Cardiovascular Surgeon
11. Australia and New Zealand Faculty of Radiation Oncology Lung Interest Cooperative: 2015 consensus guidelines for the use of advanced technologies in the radiation therapy treatment of locally advanced non‐small cell lung cancer
    Patrick M Dwyer, Louis Lao, Jeremy Ruben, Mei Ling Yap, Shankar Siva, Fiona Hegi‐Johnson, Nicholas Hardcastle, Jeffrey Barber, Margot Lehman, David Ball et al. · 2016 · Journal of Medical Imaging and Radiation Oncology
12. The long-waited high level evidence in thoracic surgery
    Cheng‐Che Tu, Po‐Kuei Hsu · 2016 · Annals of Translational Medicine
13. Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies
    Jerold Loh, Yvonne Li En Ang, Amit Jain, Joe Poh-Sheng Yeong, Raghav Sundar · 2022 · JCO Precision Oncology
14. Multivariate analysis of prognostic factors in patients with lung cancer
    Changjiang Liu, Minting Ma, Xuetao Zhou, Zefeng Zhang, Yang Guo · 2023 · Frontiers in Oncology
15. Survival Rate of Lung Adenocarcinoma Patients Receiving EGFR - Tyrosine Kinase Inhibitor Targeted Therapy
    Ungky Agus Setyawan, Rezki Tantular, Chaerani Bahar · 2023 · Jurnal Kedokteran Brawijaya
16. Safety and efficacy of targeted agents monotherapy in advanced NSCLC
    Qi Zhang, Yi-Long Lung Cancer Wu · 2015 · Expert Review of Clinical Pharmacology
17. Toxicidad asociada a la inhibición de EGFR: Revisión y aspectos clave del manejo de afatinib
    Álvaro Taus · 2016 · Medicina Clínica
18. 124: Detection of Local Cancer Recurrence after Stereotactic Ablative Radiotherapy (SABR) for Lung Cancer: Physician Performance Versus Radiomic Assessment
    Sarah A. Mattonen, David A. Palma, Carol Johnson, Alexander V. Louie, Mark S. Landis, George Rodrigues, Ian Y. M. Chan, Roya Etemad‐Rezai, Timothy Pok Chi Yeung, Suresh Senan et al. · 2016 · Radiotherapy and Oncology
19. A lung adenocarcinoma patient with EGFR mutation in exon 18 and ALK-rearrangement who treated with erlotinib and crizotinib
    Mehmet Artaç, Levent Korkmaz, Mustafa Karaağaç, Buğra Kaya, Necdet Poyraz, Hakan Özön, Zehra Er, Lema Tavlı · 2018 · Journal of Oncological Sciences
20. Automated and robust estimation framework for lung tumor location in kilovolt cone-beam computed tomography images for target-based patient positioning in lung stereotactic body radiotherapy
    Satoshi Yoshidome, Hidetaka Arimura, Kotaro Terashima, Masakazu Hirakawa, Taka‐aki Hirose, Junichi Fukunaga, Yasuhiko Nakamura, Hiroshi Honda · 2018 · Medical Imaging and Information Sciences
21. RNA-Seq Analysis: Methods, Applications and Challenges
    Autori vari, Geraci, F., Saha, I., Bianchini, M. · 2020 · Frontiers research topics
22. Methylation Biomarkers with Discriminating Ability are Potential Therapeutic Targets in Lung Adenocarcinoma
    Weiwei Zhao, Zhiwei Rong, Wenjie Wang, Shuang Li, Yaxin Lu, Lei Cao, Liuchao Zhang, Kai Ge Yang, Kui Deng, Chunyan Yang et al. · 2020 · Epigenomics
23. Ordering and Interpreting Precision Oncology Studies for Adults With Advanced Solid Tumors: A Primer
    Bruce Montgomery · 2022 · Federal Practitioner
24. Thoracoscopic lobectomy for clinical N2 and N1 lung cancer: Innovation outpacing standard of care
    Bryan M. Burt · 2017 · Journal of Thoracic and Cardiovascular Surgery
25. Clarity and clairvoyance: Review and prediction of management guidelines for early stage lung cancer
    Bryan M. Burt · 2017 · Journal of Thoracic and Cardiovascular Surgery
26. How to determine surgical management in octogenarian patients with lung cancer?
    Dohun Kim · 2023 · Journal of Thoracic Disease
27. Rebuttal from Prof. Kong and Dr. Rabatic
    B.M. Rabatic, Feng‐Ming Kong · 2016 · Translational Lung Cancer Research
28. Estimation of Recurrence Risk After Normal 18 F-FDG PET/CT in Nonsmall-Cell Lung Cancer
    Kyoungjune Pak, Seong‐Jang Kim, Phillip J. Koo, Samuel Chang · 2016 · Cancer Biotherapy and Radiopharmaceuticals
29. Effect of protein tyrosine phosphatase non-receptor type 12 (PTPN12) downregulation on the radiosensitivity of non-small cell lung cancer
    Wenxia Hu, Zhikun Liu, Weili Zhang, Scott M. Welford, Jingwei Su · 2016 · Clinical Oncology and Cancer Research
30. A Review of Current Radiation Therapies for the Treatment of Metastatic Brain Tumors
    Jonathan S. Hayman · 2017 · InTech eBooks
31. Controversy and perspective in the management of marginally operable stage IIIA non-small cell lung cancer: response to Editorial by Charlotte Billiet and Dirk De Ruysscher and Editorial by Dr. Wanpu Yan and Dr. David R. Jones
    Kailin Yang, Jiunn‐Song Jiang, Kwan‐Hwa Chi · 2017 · Journal of Thoracic Disease
32. Outcomes of adjuvant epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) treatment for EGFR-mutant non-small-cell lung cancer: a propensity-score analysis
    Shufen Zhao, G. M., Jing Guo, Aiping Ding, Shasha Wang, Guohong Yu, Lei Chen, Yonggang Yuan, Wenjing Xiao · 2017 · Scientific Reports
33. What is the optimal adjuvant therapy for T3N0 lung cancer invading the chest wall?
    Makoto Suzuki, Takeshi Mori, Kenji Shiraishi, Koei Ikeda, Yoshiko Murakami Masuda, Eri Matsubara, Chika Shirakami, Hironori Hinokuma · 2017 · Journal of Thoracic Disease
34. Adjuvant chemotherapy for resected earlier stage adenocarcinomas with unfavorable architecture. Should we incorporate histologic findings to the decision tree?
    Eric Vallières · 2017 · Journal of Thoracic and Cardiovascular Surgery
35. The Pulmonologist-Patient Relationship After the Lung Cancer Committee Decision
    Jesús Hernández Hernández · 2018 · Archivos de Bronconeumología
36. CORRELATION BETWEEN THE FDG UPTAKE OF PRIMARY TUMOUR AND METASTATIC MEDIASTINAL LYMPH NODES IN NON SMALL CELL LUNG CARCINOMA
    Arunan Murali, Gokulakrishnan Periakaruppan, Bhasker Raj, Venkata Sai · 2018 · Journal of Evidence Based Medicine and Healthcare
37. Correlation and Predictive Value of the FDG uptake within Primary Mass in Non-small Cell Lung Carcinoma and Incidence of Distal Metastases
    P.R. Gokulakrishnan, Arunan Murali, hasker Raj, Venkata Sai · 2018 · International Journal of Contemporary Medicine Surgery and Radiology
38. Category V: Suspicious for Malignancy
    Leslie G. Dodd, Allen Cole Burks · 2018 · Springer eBooks
39. Editorial on comparison between stereotactic body radiotherapy and surgery in early stage NCSLC by Scotti et al.
    Hideomi Yamashita · 2019 · Journal of Thoracic Disease
40. Role of Endobronchial Ultrasound (EBUS) in Staging of Lung Cancer
    M.Sc. GAMAL A. EL-KHOLY EMAD H. HELAL, M.D. IBRAHIM S. IBRAHIM ADEL S. BEDIWY, M.D. AYMAN M. EL-SAKKA MOHAMMED S. HANTERA · 2018 · The Medical Journal of Cairo University/The Medical Journal of Cairo University
41. Synchronous primary lung sarcomatous carcinoma and lung squamous cell carcinoma: a case report.
    Maoyuan Zhao, Qiuyang Jing, Zhouguang Hui · 2020 · PubMed Central
42. Perfil molecular tumoral del cáncer pulmonar medido por secuenciación de nueva generación
    Jorge Alatorre-Alexander, Patricio Santillán‐Doherty, Luis Manuel Martínez-Barrera, Jerónimo Rafael Rodríguez‐Cid, María del Rosario Flores-Soto, Carla Paola Sánchez‐Ríos · 2020 · NCT Neumología y Cirugía de Tórax
43. Relationship Between Expression of MAGE-A3 with The Histopathology in NSCLC Patients
    Mokhammad Mukhlis, Isnin Anang Marhana · 2020 · Jurnal Respirologi Indonesia
44. Liquid‐based cell suspension of supraclavicular lymph node fine‐needle aspirate as an alternative specimen for NGS‐based genomic profiling in advanced lung cancer
    Xun Zhang, Ying Chen, Li Chu, Jianjiao Ni, Analyn Lizaso, Bing Li, Xiaoqian Guan, Hao Liu, Guodong Li, Zhengfei Zhu · 2020 · Clinical and Translational Medicine
45. Real-world Outcomes of First-line Afatinib in Patients with Non-small Cell Lung Cancer and Uncommon EGFR Mutations in South Korea
    Mi‐Hyun Kim, Chang‐Min Choi, Sung Yong Lee, Cheol‐Kyu Park, Yoon Soo Chang, Kye Young Lee, Seung Joon Kim, Tae Won Jang, Sei Hoon Yang, Jeong‐Seon Ryu et al. · 2021 · Research Square
46. PET/CT in the Evaluation of Treatment Response in Lung Cancer
    Özlem Özmen · 2021 · Nuclear Medicine Seminars
47. Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
    Jinhai Tang, Hong-yu Shen, Jin Zhang, Di Xu, Zheng Xu, Ming‐Xing Liang, Wenquan Chen, Wenjia Xia · 2022 · Research Square
48. Chemotherapy in Lung Cancer With Hepatic and Renal Impairment
    Aida Hastuti, Erna Kusumawardhani, Haryati Haryati · 2022 · Respiratory Science
49. Clinical Target Volume Automatic Segmentation Based on Lymph Node Stations for Lung Cancer with Bulky Lump Lymph Nodes
    Mingyi Di, Jing Shen, Shaobin Wang, Qi Chen, Yu Chen, Zhikai Liu, Xin Lian, Jiabin Ma, Yantian Pang, Tingting Dong et al. · 2022 · Research Square
50. A systems model to support the implementation of a whole genome sequencing for lung cancer patients in a constrained healthcare system
    Michiel van de Ven · 2022
51. The pattern of alternative splicing in lung adenocarcinoma shows novel events correlated with tumorigenesis and immune microenvironment
    Gongjun Wang, Weiwei Qi, Liwei Shen, Shasha Wang, Ruoxi Xiao, Wenqian Li, Yuqi Zhang, Xiaoqian Bian, Libin Sun, Wensheng Qiu · 2021 · BMC Pulmonary Medicine
52. Platinum Plus Gemcitabine as the Most Effective Regimen in the First Line of Chemotherapy in Advanced Squamous Cell Lung Cancer
    2017 · Cancer Studies and Therapeutics
53. Efficacy and safety of pembrolizumab monotherapy in advanced non-small cell lung cancer patients treated at Hanoi Medical University Hospital
    Trinh Le Huy, Đình Anh Trần · 2022 · Tạp chí Nghiên cứu Y học
54. Prognostic nomogram and novel risk-scoring system for small cell lung cancer with different patterns of metastases
    Hongli Ruan, Huali Sun, Yu Feng Guo, Yan Ding, Yanmei Liu, Shenpeng Ying, Peipei Lin · 2022 · General Thoracic and Cardiovascular Surgery
55. Mir-556-3p Inhibits SqCLC via NUAK1
    Yini Cai, Ming Fang, Gong-Ji Yao, Lingmin Liao, Long Huang · 2022 · International Journal of Surgery Oncology
56. Data from Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice
    Xiuning Le, Hiroshi Sakai, Enriqueta Felip, Rémi Veillon, Marina Chiara Garassino, Jo Raskin, Alexis Benjamin Cortot, Santiago Viteri, Julien Mazières, Egbert Frederik Smit et al. · 2023
57. Data from Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets
    Catherine G. Fischer, Aparna Pallavajjala, Liqun Jiang, Valsamo Anagnostou, Jessica J. Tao, Emily Adams, James R. Eshleman, Christopher D. Gocke, Ming-Tseh Lin, Elizabeth A. Platz et al. · 2023
58. Data from Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets
    Catherine G. Fischer, Aparna Pallavajjala, Liqun Jiang, Valsamo Anagnostou, Jessica J. Tao, Emily Adams, James R. Eshleman, Christopher D. Gocke, Ming-Tseh Lin, Elizabeth A. Platz et al. · 2023
59. Tissue Acquisition in Patients with Suspected Lung Cancer: Techniques Available and Sampling Adequacy for Molecular Testing
    Semra Bilaçeroğlu · 2023 · Springer eBooks
60. Expression of MAGE-A3 in and histopathological analysis of forceps biopsy specimens of non– small-cell lung carcinoma patients
    Isnin Anang Marhana, Muhammad Amin, Gondo Mastutik, Mokhammad Mukhlis · 2022 · Pneumologia
61. Cancer immunotherapy in second-line treatment of non-small cell lung cancer – is there a need to change the approach to the assessment of clinical benefits?
    Anna Panasiuk, Małgorzata Budasz-Świderska, Marcin Kaczor · 2018 · Journal of Health Policy & Outcomes Research
62. Analysis of the effect of surgery on the prognosis of non-small cell lung cancer patients with single-organ extrathoracic metastases based on the SEER database
    Lijing Zheng, Weishuai Wu, Shiyin Luo, Yuanfeng Lin, Jingyu Wu, Chen Huang, Qianshun Chen, Yidan Lin, Xunyu Xu, Yongmei Dai · 2023 · Research Square
63. Nomogram Using Intratumoral and Peritumoral Radiomics For the Preoperative Prediction of Visceral Pleural Invasion in Clinical Stage IA Lung Adenocarcinoma
    Yun Wang, Deng Lyu, Su Hu, Yanqing Ma, Shaofeng Duan, Yayuan Geng, Taohu Zhou, Wenting Tu, Yi Xiao, Li Fan et al. · 2023 · Research Square
64. Using Next Generation Sequencing (NGS) tests in routine oncology practice in Croatia: Results of a nationally representative survey of oncologists
    Renata Kelemenić-Dražin, Anuška Budisavljević · 2023 · Liječnički vjesnik
65. Low-dose SAHA enhances CD8+T cell-mediated antitumor immunity by upregulating MHC I expression in non-small cell lung cancers
    Baolong Wang, Bing He, Yanhong Cao, Rui Yang, Shuang Zhang, Yujie Kong, Dapeng Lu, Peng Luo, Zheng Xu, Yanjiao Hou et al. · 2023 · Research Square
66. Rhizopogon luteolusand Ganoderma adspersum extracts inhibit invasion through the crosstalk antioxidant activity and apoptosis induced by pAKT/Rb
    Aydın Demiray, Ege Rıza Karagür, Gülsen Tel‐Çayan, Onur Tokgün, Hakan Akça, Mehmet Emin Duru · 2023 · Research Square
67. Additional file 3 of Circular RNA hsa_circ_0000326 acts as a miR-338-3p sponge to facilitate lung adenocarcinoma progression
    Yuzhu Xu, Jun Qing Yu, Zhen‐Li Huang, Bohua Fu, Tao, Yu, Xuefei Qi, Yong Mou, Yinan Hu, Yi Wang, Yong Cao et al. · 2020 · Figshare
68. Usual Lung Cancers
    Lucian R. Chirieac, Richard Luther Attanoos · 2024 · Elsevier eBooks
69. The Specific Genomic Alterations and Molecular Mechanisms of Liver Metastases in Patients with Lung Adenocarcinoma
    Lingyi Yang, Linbo Gao, Ruiqi Qian, Xiuqin Zhang, Xu-Rui Shen · 2025 · Cancer Investigation
70. Pemigatinib in the treatment of metastatic intrahepatic cholangiocellular carcinoma with FGFR2 alteration
    Martin Palkovský, Marián Liberko, Renata Soumarová · 2025 · Onkologie
71. Additional file 1 of Circular RNA hsa_circ_0000326 acts as a miR-338-3p sponge to facilitate lung adenocarcinoma progression
    Xu, Yuzhu, Yu, Jun, Huang, Zhenli, Bohua Fu, Tao, Yu, Qi, Xuefei, Mou, Yong, Hu, Yinan, Wang, Yi, Cao, Yong et al. · 2020 · Figshare
72. Additional file 4 of Circular RNA hsa_circ_0000326 acts as a miR-338-3p sponge to facilitate lung adenocarcinoma progression
    Xu, Yuzhu, Yu, Jun, Huang, Zhenli, Bohua Fu, Tao, Yu, Xuefei Qi, Mou, Yong, Hu, Yinan, Wang, Yi, Cao, Yong et al. · 2020 · Figshare
73. Additional file 1 of Nomogram using intratumoral and peritumoral radiomics for the preoperative prediction of visceral pleural invasion in clinical stage IA lung adenocarcinoma
    Wang, Yun, Deng Lyu, Hu, Su, Yanqing Ma, Duan, Shaofeng, Geng, Yayuan, Zhou, Taohu, Tu, Wenting, Xiao, Yi, Fan, Li et al. · 2024 · Figshare
74. Additional file 5 of Circular RNA hsa_circ_0000326 acts as a miR-338-3p sponge to facilitate lung adenocarcinoma progression
    Xu, Yuzhu, Yu, Jun, Huang, Zhenli, Bohua Fu, Tao, Yu, Qi, Xuefei, Mou, Yong, Hu, Yinan, Wang, Yi, Yong Cao et al. · 2020 · Figshare
75. Additional file 2 of Circular RNA hsa_circ_0000326 acts as a miR-338-3p sponge to facilitate lung adenocarcinoma progression
    Xu, Yuzhu, Yu, Jun, Huang, Zhenli, Bohua Fu, Tao, Yu, Xuefei Qi, Mou, Yong, Hu, Yinan, Wang, Yi, Yong Cao et al. · 2020 · Figshare
76. Additional file 1 of Associations of genetic risk, BMI trajectories, and the risk of non-small cell lung cancer: a population-based cohort study
    Dongfang You, Wang, Danhua, Yaqian Wu, Chen, Xin, Fang Shao, Wei, Yongyue, Zhang, Ruyang, Lange, Theis, Ma, Hongxia, Xu, Hongyang et al. · 2022 · Figshare
77. Machine learning prediction of postoperative pulmonary infection in patients who underwent thoracoscopic lung cancer resection: a retrospective case–control study
    Jiajia Ma, Zhengmin Zhang, Bei Xue, Jing Feng, Liping Yao, H Z Chen, Xiaoxin Liu · 2026 · BMC Medical Informatics and Decision Making
78. Serum Hsp90-β as a Diagnostic and Prognostic Biomarker in Lung Cancer: A Prospective Case–Control Study
    Sanjeev Kumar Binji, Ankita Singh, Shivani Jaswal, Kranti Garg, Uma Handa, Varinder Saini, Jasbinder Kaur · 2026 · Indian Journal of Medical Biochemistry
79. Advances in Pathology: Journal of Thoracic Oncology 20th Anniversary Series
    William David Travis, Marina K. Baine, Mary Beth Beasley, E. Brambilla, Lukas Bubendorf, Allen Burke, Andrew Churg, Wendy Cooper, Sanja Đačić, F. Galateau Salle et al. · 2026 · Journal of Thoracic Oncology